Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Oct 13;10(10):e6418.
doi: 10.1002/ccr3.6418. eCollection 2022 Oct.

A case of left foot drop as initial symptom of granulomatosis with polyangiitis: Triggered by COVID-19 disease?

Marjolaine Weynand  1 , Ioannis Raftakis  1 , Yassine Mohammad Chérif  1 , Sophie Lecomte  2 , Valérie Badot  1
Affiliations
Case Reports

A case of left foot drop as initial symptom of granulomatosis with polyangiitis: Triggered by COVID-19 disease?

Marjolaine Weynand et al. Clin Case Rep. .

Abstract

In Granulomatosis with polyangiitis (GPA), involvement of the peripheral nervous system is frequent but its occurrence as an initial presentation is unusual. This case highlights the importance of this occurrence to permit an early diagnosis. Moreover, GPA started after a coronavirus disease 2019 infection and could have been induced by this.

Keywords: ear, nose and throat; neurology; ophthalmology; rheumatology.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest for any authors.

Figures

FIGURE 1
FIGURE 1
External appearance of the diffuse anterior scleritis with widespread inflammation of sclera. The scleral plexus remains visible after phenylephrine.
FIGURE 2
FIGURE 2
Superficial peroneal nerve biopsy with two nerve fascicles demonstrating perivasculitis with mononuclear cell infiltration surrounding small vessels.
See this image and copyright information in PMC

References

    1. Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev. 2014;13(11):1121‐1125. - PubMed
    1. Puéchal X, Pagnoux C, Perrodeau É, et al. Long‐term outcomes among participants in the WEGENT trial of remission‐maintenance therapy for granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis. Arthritis Rheumatol. 2016;68(3):690‐701. - PubMed
    1. Wolf J, Schmitt V, Palm F, Grau AJ, Bergner R. Peripheral neuropathy as initial manifestation of primary systemic vasculitides. J Neurol. 2013;260(4):1061‐1070. - PubMed
    1. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo clinic. Ann Neurol. 1993;33(1):4‐9. - PubMed
    1. de Groot K, Schmidt DK, Arlt AC, Gross WL, Reinhold‐Keller E. Standardizaed neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol. 2001;58:1215‐1221. - PubMed

Publication types

LinkOut - more resources